AGM
NUVB icon

Alpine Global Management’s Nuvation Bio NUVB Stock Holding History

Alpine Global Management’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-37,566
Closed -$110K – 364
2024
Q2 		$110K Buy
+37,566
New +$115K 0.02% 397
2021
Q1 		– Sell
-200,000
Closed -$2.34M – 355
2020
Q4 		$2.34M Buy
+200,000
New +$2.08M 0.47% 33

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

Alpine Global Management's NUVB Position: Q3 2024 in Review

Alpine Global Management sold out of Nuvation Bio (NUVB) in Q3 2024, closing a stake of 37,566 shares — an estimated $110K sold.

Alpine Global Management first reported a position in NUVB in Q4 2020 and held it in 2 quarters. The position peaked at $2.34M in Q4 2020. 154 funds tracked by Wall St. Rank hold NUVB as of Q3 2024.

  • Alpine Global Management reported no remaining Nuvation Bio position as of Q3 2024 after selling out during the quarter.
  • Alpine Global Management sold 37,566 Nuvation Bio shares in Q3 2024, an estimated $110K.
  • Alpine Global Management first reported a position in Nuvation Bio in Q4 2020 and held it in 2 quarters.
  • Alpine Global Management's Nuvation Bio position peaked at $2.34M in Q4 2020.
  • 154 funds tracked by Wall St. Rank held Nuvation Bio as of Q3 2024.

Based on Alpine Global Management's 13F filing for Q3 2024, filed 14 Nov 2024.